Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing

Journal of Clinical Lipidology

Volumn 4, Issue 2, 2010, Pages 120-125

  Gerrald, Katherine R ^a   Dixon, Dave L ^a,b   Barnette, Debra J ^a,c   Williams, Virginia G ^a,c  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b CAMPBELL UNIVERSITY   (United States)

^c WINGATE UNIVERSITY   (United States)

Author keywords

Clinical pharmacy service; Coronary heart disease; Lipid management; Point of care testing

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PHARMACY; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PHARMACIST; POINT OF CARE TESTING; PRIORITY JOURNAL;

AGED; BLOOD CHEMICAL ANALYSIS; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; NORTH CAROLINA; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENT CLINICS, HOSPITAL; PHARMACISTS; POINT-OF-CARE SYSTEMS; RETROSPECTIVE STUDIES;

EID: 77949858353     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.02.001     Document Type: Article

References (25)

1. Lloyd-Jones D., Adams R., Carnethon M., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2009 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) e21-e181
2. Pedersen T.R., Kjekshus J., Berg K., et al., for the Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
3. Shepherd J., Covve S.M., Ford I., et al., for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Eng J Med 333 (1995) 1301-1307
4. Grundy S.M., Cleeman J.I., Merz C.N., et al., for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110 (2004) 227-239
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 2486-2497
6. Waters D.D., Brotons C., Chiang C.-W., et al., for the Lipid Treatment Assessment Project 2 Investigators. Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation 120 (2009) 28-34
7. Cross L.B., and Franks A.S. Clinical outcomes associated with pharmacist involvement in patients with hyperlipidemia. Dis Manage Health Outcomes 13 (2005) 31-42
8. Straka R.J., Taheri R., Cooper S.L., and Smith J.C. Achieving cholesterol target in a managed care organization (ACTION) trial. Pharmacotherapy 25 (2005) 360-371
9. Bozovich M., Rubino C.M., and Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on achieving national cholesterol education program low-density lipoprotein goals. Pharmacotherapy 20 (2000) 1375-1383
10. Geber J., Parra D., Beckey N.P., and Korman L. Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting. Pharmacotherapy 22 (2002) 738-747
11. O'Donnell D.C., Chen N., and Piziak V.K. Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic. Am J Health-Syst Pharm 58 (2001) 325-330
12. Till L.T., Voris J.C., and Horst J.B. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 3 (2003) 269-273
13. Mazzolini T.A., Irons B.K., Schell E.C., and Seifert C.F. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA medical centers. J Manag Care Pharm 11 (2005) 763-771
14. DiTusa L., Luzier A., Brady G., Reinhardt M., and Snyder B.D. A pharmacy-based approach to cholesterol management. Am J Manag Care 7 (2001) 973-979
15. Bluml B.M., McKenney J.M., and Cziraky M.J. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc 40 (2000) 157-165
16. Rasmussen J.N., Chong A., and Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297 (2007) 177-186
17. Brookhart M.A., Patrick A.R., Schneeweiss S., et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med 167 (2007) 847-852
18. Yilmaz M.B., Pinar M., Naharci I., et al. Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther 19 (2005) 437-440
19. Machado M., Nassor N., Bajcar J.M., Guzzo G.C., and Einarson T.R. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother 42 (2008) 1195-1207
20. Sharma M., Ansari M.T., Abou-Setta A.M., et al. Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia. Ann Intern Med 151 (2009) 622-630
21. Taylor J., and Lopez L. Cholesterol: point-of-care testing. Ann Pharmacother (2004) 1252-1257
22. Casalino L.P., Dunham D., Chin M.H., et al. Frequency of failure to inform patients of clinically significant outpatient test results. Arch Intern Med 169 (2009) 1123-1129
23. National Cholesterol Education Program Working Group on Lipoprotein Measurement. Recommendations on lipoprotein measurement (1995), US Department of Health and Human Services, Washington, DC NIH publication no. 65-3044
24. Santee J. Accuracy and precision of the Cholestech LDX System in monitoring blood lipid levels. Am J Health-Syst Pharm 59 (2002) 1774-1779
25. Dale R.A., Jensen L.H., and Krantz M.J. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Ann Pharmacother 42 (2008) 633-639